Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring (NCT06668935)

🧪 Interventions in This Study

• To utilize the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) to help prolong the length of time people with diabetes maintain adherence to GLP-1 and dual GIP/GLP-1 agonists (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• East Coast Institute for Research, LLC — Jacksonville, Florida
• Excellence Medical and Research — Miami Gardens, Florida

📞 Contact the Study Coordinator

Phone: (510) 749-5416

Email: adc.clinical@abbott.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Diabetes Mellitus

• The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes — Boston, Massachusetts
• Oral Anti Diabetic Agents in the Hospital — Atlanta, Georgia
• Full Plate Living Nutrition Education Program — Madison, Wisconsin
• Evaluation of Arts-Based Storytelling Program in Adolescents With Diabetes — San Francisco, California
• Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes — Cleveland, Ohio
• Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years — Charlestown, Massachusetts

Explore by condition: All Diabetes Mellitus clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.